MA53508A - Cristal de pyrazolo[3,4-d]pyrimidine - Google Patents

Cristal de pyrazolo[3,4-d]pyrimidine

Info

Publication number
MA53508A
MA53508A MA053508A MA53508A MA53508A MA 53508 A MA53508 A MA 53508A MA 053508 A MA053508 A MA 053508A MA 53508 A MA53508 A MA 53508A MA 53508 A MA53508 A MA 53508A
Authority
MA
Morocco
Prior art keywords
pyrazolo
pyrimidine
crystal
pyrimidine crystal
Prior art date
Application number
MA053508A
Other languages
English (en)
Inventor
Hiromi Oshiumi
Tadashi Shimamura
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of MA53508A publication Critical patent/MA53508A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA053508A 2018-08-29 2019-08-28 Cristal de pyrazolo[3,4-d]pyrimidine MA53508A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018159840 2018-08-29

Publications (1)

Publication Number Publication Date
MA53508A true MA53508A (fr) 2022-05-11

Family

ID=69644316

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053508A MA53508A (fr) 2018-08-29 2019-08-28 Cristal de pyrazolo[3,4-d]pyrimidine

Country Status (7)

Country Link
US (1) US12215109B2 (fr)
EP (1) EP3845537B1 (fr)
JP (1) JP7282787B2 (fr)
CN (1) CN112638914A (fr)
ES (1) ES3039287T3 (fr)
MA (1) MA53508A (fr)
WO (1) WO2020045475A1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112018004175B8 (pt) 2015-09-01 2023-10-31 Taiho Pharmaceutical Co Ltd Composto pirazolo[3,4-d]pirimidina, composição farmacêutica e usos terapêuticos do dito composto

Also Published As

Publication number Publication date
EP3845537A1 (fr) 2021-07-07
JPWO2020045475A1 (ja) 2021-08-10
US12215109B2 (en) 2025-02-04
EP3845537B1 (fr) 2025-07-30
EP3845537A4 (fr) 2022-05-11
CN112638914A (zh) 2021-04-09
ES3039287T3 (en) 2025-10-20
WO2020045475A1 (fr) 2020-03-05
US20210332056A1 (en) 2021-10-28
JP7282787B2 (ja) 2023-05-29

Similar Documents

Publication Publication Date Title
DK3762385T3 (da) Substituerede 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-oner
EP3980010A4 (fr) Composés de pyrazolo[1,5-a]pyrimidine 2,3,5-trisubstitués
SG11201801365YA (en) NOVEL PYRAZOLO[3,4-d]PYRIMIDINE COMPOUND OR SALT THEREOF
EP3661918A4 (fr) Analogues de 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-one
DK3800189T3 (da) Fremstilling af (s)-n-(5-((r)-2-(2,5-difluorphenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidin-1-carboxamid
HUE057549T2 (hu) Imidazo[1,2-a]pirimidinszármazékok, eljárás elõállításukra és alkalmazásaik
EP3744723A4 (fr) Composé macrocyclique de pyrazolo [1,5-a]pyrimidine substitué
EP3660019C0 (fr) 7h-pyrazolo[3,4-d]triazine-2-oxides en tant qu'explosifs
DK3442975T3 (da) 1,5-dihydro-4h-pyrazolo[3,4-d]pyrimidin-4-oner og 1,5-dihydro-4h-pyrazolo[4,3-c]pyridin-4-oner som pde1-inhibitorer
EP3508487A4 (fr) COMPOSÉ DE PYRAZOLO [1,5-a]PYRIMIDINE
LT3820872T (lt) Pirolo[1,2-b]piridazino dariniai
DK3412673T3 (da) Fremgangsmåde til fremstilling af pyrrolo[3,2-D]pyrimidin-forbindelse og mellemprodukter deraf
DK3596080T3 (da) Farmakologisk aktive alicyclisk-substitueret pyrazolo[1,5-a]pyrimidin-derivater
DK3737684T3 (da) 2,4,6,7-tetrahydro-pyrazolo[4,3-d]pyrimidin-5-on-derivater og relaterede forbindelser som c5a-receptormodulatorer til behandling af vaskulitis og inflammatoriske sygdomme
IL262711A (en) History of a [3,2,1]triazolo[5,4-d]pyrimidine with affinity for the type 2 cannabinoid receptor
DK3459953T3 (da) Hidtil ukendt 5h-pyrrolo[2,3-d]pyrimidin-6(7h)-on-derivat
EP3590516A4 (fr) Activateur d'effet antitumoral utilisant un composé pyrazolo[3,4-d]pyrimidine
EP3730492A4 (fr) Composé pyrazolo[1,5-a]pyrimidine substitué, composition pharmaceutique et utilisation associée
MX381037B (es) Formas cristalinas y formas de sal de compuestos de 7h-pirrolo [2,3-d]pirimidina y método de preparación de las mismas.
EP3845537A4 (fr) Cristal de pyrazolo[3,4-d]pyrimidine
EP3546456A4 (fr) Cristal de dérivé de pyrido [3, 4-d]pyrimidine ou son solvate
GB201910656D0 (en) New use of triazolo(4,5-d)Pyrimidine deerivatives
EP3903788A4 (fr) Composé macrocyclique de pyrazolo[1,5-a] pyrimidine
HUE052997T2 (hu) JAK kináz inhibitor pirazol[1,5-a]pirimidin származékok
IL253427B (en) The result of pyrazolo[3,4-d]pyrimidine and its use in the treatment of Jericho rose